Viral hepatitis in 1996;Hépatites virales

Medecine et Hygiene

Volumn 55, Issue 2148, 1997, Pages 203-206

  Negro, F ^a   Giostra, E ^a   Margalith, D ^b   Thorens, J ^b   Gonvers, J J ^b   Hadengue, A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; HYPERIMMUNE GLOBULIN; LAMIVUDINE;

HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; ORAL DRUG ADMINISTRATION; SHORT SURVEY; VIRUS HEPATITIS;

EID: 2542543694     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Alter HJ. The cloning and clinical implications of HGV and GBV-C. N Engl J Med 1996 ; 334 : 1537-8.
2. Bader TF. Hepatitis A vaccine. Am J Gastroenterol 1996 ; 91 : 217-22.
3. Cammà C, Almasio P, Craxi' A. Interferon as treatment for acute hepatitis C. A meta-analysis. Dig Dis Sci 1996 ; 41 : 1248-55.
4. Carman WF, Trautwein C, van Deirsen FJ, et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996 ; 24 : 489-93.
5. Chayama K, Tsubota A, Arase Y, et al. Genotype, slow decrease in virus titer during interferon treatment and high degree of sequence variability of hypervariable region are indicative of poor response to interferon treatment in patients with chronic hepatitis type C. J Hepatol 1995 ; 23 : 648-53.
6. Chemello L, Cavalletto L, Casarin C. et al. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-α in chronic hepatitis C. Ann Intern Med 1996 ; 124 : 1058-60.
7. Chiaramonte M, Stroffolini T, Lorenzoni U, et al. Risk factors in community-acquired chronic hepatitis C virus infection : A case-control study in Italy. J Hepatol 1996 ; 24 : 129-34.
8. Dienstag JL, Perrillo RP, Schiff ER, et al. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995 ; 333 : 1657-61.
9. Enomoto N, Sakuma I, Asahina Y, et al. Mutations in the nonstructural protein SA gene and response to interferon in patients with chronic hepatitis C virus Ib infection. N Engl J Med 1996 ; 334 : 77-81.
10. Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996 ; 334 : 555-60.
11. Fattovich G, Giustina G, Favarato S, et al. A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996 ; 24 : 38-47.
12. Gone EJ, Portmann BC, Naoumov NV, et al Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996 ; 334 : 815-20.
13. Gish RG, Lau JYN, Brooks L, et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996 ; 23 : 1-7.
14. Gregorio GV, Jara P, Hierro L, et al. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B : A multicenter controlled trial. Hepatology 1996 ; 23 : 700-7.
15. Harpaz R, Von Seidlein L, Averhoff FM, et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 1996 ; 334 : 549-54.
16. Izumi N, Enomoto N, Uchihara M, et al. Hepatic iron contents and response to interferon-α in patients with chronic hepatitis C. Dig Dis Sci 1996 ; 41 : 989-94.
17. Koff RS. Preventing hepatitis A infections in travelers to endemic areas. Am J Trop Med Hyg 1995 ; 53 : 586-90.
18. Leary TP, Muerhoff AS, Simons JN, et al. Consensus oligonucleotide primers for the detection of GB virus C in human cryptogenic hepatitis. J Virol Methods 1996 ; 56 : 119-21.
19. Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996 ; 24 : 711-3.
20. Linnen J, Wages JJr, Zhang-Keck Z-Y, et al. Molecular cloning and disease association of hepatitis G virus : A transfusion-transmissible agent. Science 1996 ; 271 : 505-8.
21. Masuko K, Mitsui T, Iwano K, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996 ; 334 : 1485-90.
22. Nguyen TT, Sedghi-Vaziri A, Wilkes LB, et al. Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection. J Viral Hep 1996 ; 3 : 75-8.
23. Niederau C, Heintges T, Lange S, et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996 ; 334 : 1422-7.
24. Pawlotsky J-M, Darhuy F, Rémiré J, et al. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C. J Med Virol 1995 ; 47 : 285-91.
25. Poynard T, Leroy V, Cohard M, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C : Effects of dose and duration. Hepatology 1996 ; 24 : 778-89.
26. Prieto J, Yuste JR, Beloqui O, et al. Anticardiolipin antibodies in chronic hepatitis C : Implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996 ; 23 : 199-204.
27. Tipples GA, Ma MM, Fischer KP, et al. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996 ; 24 : 714-7.
28. Van Thiel DH, Caraceni P, Molloy PJ, et al. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels : The role of interferon α2b therapy. J Hepatol 1995 ; 23 : 503-8.
29. Vento S, Cainelli F, Mirandola F, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996 ; 347 : 92-3.